Mathijs A. Sanders

11.6k citations
75 papers · 3.3k · 1 hit paper · h-index 29

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 2%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

  • Hematology 39
    • Acute Myeloid Leukemia Research 32
    • Chronic Myeloid Leukemia Treatments 7
    • Multiple Myeloma Research and Treatments 6
  • Molecular Biology 37
    • Epigenetics and DNA Methylation 9
    • Protein Degradation and Inhibitors 5
Co-authors
Peter J.M. Valk (27 shared papers)Bob Löwenberg (19 shared papers)J. L. Salisbury (5 shared papers)Ruud Delwel (11 shared papers)Claudia Erpelinck-Verschueren (11 shared papers)Andre T. Baron (1 shared paper)Maarten Bijl (2 shared papers)Roel G.W. Verhaak (3 shared papers)
Journals
Blood (23 papers)Nature Communications (4 papers)Leukemia (4 papers)Cancer Research (3 papers)HemaSphere (3 papers)
Partner nations
NetherlandsUnited StatesGermany

In The Last Decade

Mathijs A. Sanders

65 papers receiving 3.2k citations

Mathijs A. Sanders's Hit Papers

Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome 2022 · 159 citations
1590+1+2Years since publication50100150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2022 Blood

Peers

Mathijs A. Sanders
Comparison fields: 5 of 114
  • Hematology 1.6k
  • Genetics 572
  • Cancer Research 704
  • Molecular Biology 1.9k
  • Immunology 362
Replace Bert A. van der Reijden with:
Bert A. van der Reijden Netherlands
Silvia Buonamici United States
John E. Pimanda Australia
Motomi Osato Singapore
Cristina E. Tognon United States
Susumu Goyama Japan
Lucio H. Castilla United States
Anupama Narla United States
Tsukasa Okuda Japan
Jeffrey L. Kutok United States
Mathijs A. Sanders relative to Bert A. van der Reijden Netherlands Bert A. van der Reijden's profile →
Citations per field
00.5×1.5×1.9×
Bert A. van der Reijden · 1×
Citations per year

Countries citing papers authored by Mathijs A. Sanders

Since Specialization
Citations

This map shows the geographic impact of Mathijs A. Sanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathijs A. Sanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathijs A. Sanders more than expected).

Fields of papers citing papers by Mathijs A. Sanders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathijs A. Sanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathijs A. Sanders. The network helps show where Mathijs A. Sanders may publish in the future.

Co-authors

The 25 scholars most cited alongside Mathijs A. Sanders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mathijs A. Sanders Line = papers co-authored together Mathijs A. Sanders links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance
Blood ·Roel G.W. Verhaak, Chantal S. Goudswaard, Wim van Putten, Maarten Bijl, Mathijs A. Sanders, Wendy Hugens, André G. Uitterlinden, Claudia Erpelinck-Verschueren, Ruud Delwel, Bob Löwenberg, Peter J.M. Valk
2005437
2
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity
Blood ·Erdogan Taskesen, Lars Bullinger, Andrea Corbacioglu, Mathijs A. Sanders, Claudia Erpelinck-Verschueren, Bas J. Wouters, Sonja C. van der Poel-van de Luytgaarde, Frédérik Damm, Jürgen Krauter, Arnold Ganser, Richard F. Schlenk, Bob Löwenberg, Ruud Delwel, Hartmut Döhner, Peter J.M. Valk, Konstanze Döhner
2010262
3
Somatic mutations and clonal dynamics in healthy and cirrhotic human liver
Nature ·Simon Brunner, Nicola D. Roberts, Luke A. Wylie, Luiza Moore, Sarah J. Aitken, Susan Davies, Mathijs A. Sanders, Peter Ellis, Christopher Alder, Yvette Hooks, Federico Abascal, Michael R. Stratton, Iñigo Martincorena, Matthew Hoare, Peter J. Campbell
2019218
4
The centrin-based cytoskeleton of Chlamydomonas reinhardtii: distribution in interphase and mitotic cells.
The Journal of Cell Biology ·J. L. Salisbury, Andre T. Baron, Mathijs A. Sanders
1988211
5
Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
Blood ·Ana Flávia Tibúrcio Ribeiro, Marta Pratcorona, Claudia Erpelinck-Verschueren, Veronika Ročková, Mathijs A. Sanders, Saman Abbas, María E. Figueroa, Annelieke Zeilemaker, Ari Melnick, Bob Löwenberg, Peter J.M. Valk, Ruud Delwel
2012185
6
Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome
Blood ·Tim Grob, Adil S. A. Al Hinai, Mathijs A. Sanders, François G. Kavelaars, Melissa Rijken, Patrycja Gradowska, Bart J. Biemond, Dimitri Breems, Johan Maertens, Marinus van Marwijk Kooy, Thomas Pabst, Okke de Weerdt, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Gerwin Huls, Jan J. Cornelissen, H. Berna Beverloo, Bob Löwenberg, Mojca Jongen‐Lavrencic, Peter J.M. Valk
Hit paper breakdown →		2022159
7
MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome
Cancer Cell ·Vaia Stavropoulou, Susanne Kaspar, Laurent Brault, Mathijs A. Sanders, Sabine Juge, Stefano Morettini, Alexandar Tzankov, Michelina Iacovino, I‐Jun Lau, Thomas A. Milne, Hélène Royo, Michael Kyba, Peter J.M. Valk, Antoine H.F.M. Peters, Juerg Schwaller
2016151
8
RLF2, a subunit of yeast chromatin assembly factor-I, is required for telomeric chromatin function in vivo.
Genes & Development ·Shinichiro Enomoto, P D McCune-Zierath, Maryam Gerami‐Nejad, Mathijs A. Sanders, Judith Berman
1997130
9
The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape
Nature Immunology ·Madelon M.E. de Jong, Zoltán Kellermayer, Natalie Papazian, Sabrin Tahri, Davine Hofste op Bruinink, Remco M. Hoogenboezem, Mathijs A. Sanders, Pieter C. van de Woestijne, P.K. Bos, Cyrus Khandanpour, Jessica Vermeulen, Philippe Moreau, Mark van Duin, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo
2021128
10
Somatic Evolution in Non-neoplastic IBD-Affected Colon
Cell ·Sigurgeir Ólafsson, Rebecca E. McIntyre, Tim Coorens, Timothy Butler, Hyunchul Jung, Philip S. Robinson, Henry Lee-Six, Mathijs A. Sanders, Kenneth Arestang, Claire Dawson, Monika Tripathi, Konstantina Strongili, Yvette Hooks, Michael R. Stratton, Miles Parkes, Iñigo Martincorena, Tim Raine, Peter J. Campbell, Carl A. Anderson
2020127
11
Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia
Blood ·Renée Beekman, Marijke Valkhof, Mathijs A. Sanders, Paulette M. H. van Strien, Jurgen R. Haanstra, L Broeders, W. M. C. Geertsma-Kleinekoort, A. Veerman, Peter J.M. Valk, Roel G.W. Verhaak, Bob Löwenberg, Ivo P. Touw
2012125
12
Increased somatic mutation burdens in normal human cells due to defective DNA polymerases
Nature Genetics ·Philip S. Robinson, Tim Coorens, Claire Palles, Emily Mitchell, Federico Abascal, Sigurgeir Ólafsson, Bernard C. H. Lee, Andrew Lawson, Henry Lee-Six, Luiza Moore, Mathijs A. Sanders, James Hewinson, Lynn Martin, Claudia M.A. Pinna, Sara Galavotti, Raheleh Rahbari, Peter J. Campbell, Iñigo Martincorena, Ian Tomlinson, Michael R. Stratton
202194
13
MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML
Blood ·Mathijs A. Sanders, Edward Chew, Christoffer Flensburg, Annelieke Zeilemaker, Sarah E. Miller, Adil S. A. Al Hinai, Ashish Bajel, Bram Luiken, Melissa Rijken, Tamara J. McLennan, Remco M. Hoogenboezem, François G. Kavelaars, Stefan Fröhling, Marnie E. Blewitt, Eric M. Bindels, Warren S. Alexander, Bob Löwenberg, Andrew W. Roberts, Peter J.M. Valk, Ian J. Majewski
201876
14
Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia
Journal of Clinical Oncology ·Tim Grob, Mathijs A. Sanders, Christian M. Vonk, F. G. Kavelaars, Melissa Rijken, Diana Hanekamp, Patrycja Gradowska, Jacqueline Cloos, Yngvar Fløisand, Marinus van Marwijk Kooy, Markus G. Manz, Gert J. Ossenkoppele, Lidwine W. Tick, Violaine Havelange, Bob Löwenberg, Mojca Jongen‐Lavrencic, Peter J.M. Valk
202269
15
Reliable detection of somatic mutations in solid tissues by laser-capture microdissection and low-input DNA sequencing
Nature Protocols ·Peter Ellis, Luiza Moore, Mathijs A. Sanders, Timothy Butler, Simon Brunner, Henry Lee-Six, Robert J. Osborne, Ben W. Farr, Tim Coorens, Andrew Lawson, Alex Cagan, Mike Stratton, Iñigo Martincorena, Peter J. Campbell
202067
16
Mutational spectrum of myeloid malignancies with inv(3)/t(3;3) reveals a predominant involvement of RAS/RTK signaling pathways
Blood ·Stefan Gröschel, Mathijs A. Sanders, Remco M. Hoogenboezem, Annelieke Zeilemaker, Marije Havermans, Claudia Erpelinck-Verschueren, Eric M. Bindels, H. Berna Beverloo, Hartmut Döhner, Bob Löwenberg, Konstanze Döhner, Ruud Delwel, Peter J.M. Valk
201455
17
An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation
Blood ·Roberto Avellino, Marije Havermans, Claudia Erpelinck-Verschueren, Mathijs A. Sanders, Remco M. Hoogenboezem, Harmen J.G. van de Werken, Elwin Rombouts, Kirsten van Lom, Paulina M. H. van Strien, Claudia Gebhard, Michael Rehli, John E. Pimanda, Dominik Beck, Stefan J. Erkeland, Thijs Kuiken, Hans de Looper, Stefan Gröschel, Ivo P. Touw, Eric M. Bindels, Ruud Delwel
201655
18
Overexpression of the erythrocyte plasma membrane Ca2+ pump in COS-1 cells
Biochemical Journal ·Hugo P. Adamo, Anil Kumar Verma, Mathijs A. Sanders, Roger Heim, J. L. Salisbury, Eric D. Wieben, John T. Penniston
199249
19
The evolving molecular genetic landscape in acute myeloid leukaemia
Current Opinion in Hematology ·Mathijs A. Sanders, Peter J.M. Valk
201344
20
ICL-induced miR139-3p and miR199a-3p have opposite roles in hematopoietic cell expansion and leukemic transformation
Blood ·Mir Farshid Alemdehy, Jurgen R. Haanstra, Hans W. J. de Looper, Paulina M. H. van Strien, Judith Verhagen-Oldenampsen, Yvette Caljouw, Mathijs A. Sanders, Remco M. Hoogenboezem, Arnoud H. de Ru, George M. C. Janssen, Stephanie E. Smetsers, Marc Bierings, Peter A. van Veelen, Marieke von Lindern, Ivo P. Touw, Stefan J. Erkeland
201544

About Mathijs A. Sanders

Mathijs A. Sanders is a scholar working on Hematology, Molecular Biology, Cancer Research, Genetics and Immunology, having authored 75 papers that have together received 3.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (32 papers), Cancer Genomics and Diagnostics (19 papers), Epigenetics and DNA Methylation (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Acute Lymphoblastic Leukemia research (7 papers), Chronic Myeloid Leukemia Treatments (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Protein Degradation and Inhibitors (5 papers). The work is most often cited by research in Hematology (1.6k citations), Genetics (572 citations), Cancer Research (704 citations), Molecular Biology (1.9k citations) and Immunology (362 citations). Mathijs A. Sanders has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Peter J.M. Valk, Bob Löwenberg, J. L. Salisbury, Ruud Delwel, Claudia Erpelinck-Verschueren, Andre T. Baron, Maarten Bijl, Roel G.W. Verhaak, Wim van Putten and Chantal S. Goudswaard. Their work appears in journals such as Blood, Nature Communications, Leukemia, Cancer Research and HemaSphere.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bert A. van der ReijdenBreakdown of academic impact, for papers by Silvia BuonamiciBreakdown of academic impact, for papers by John E. PimandaBreakdown of academic impact, for papers by Motomi OsatoBreakdown of academic impact, for papers by Cristina E. TognonBreakdown of academic impact, for papers by Susumu GoyamaBreakdown of academic impact, for papers by Lucio H. CastillaBreakdown of academic impact, for papers by Anupama NarlaBreakdown of academic impact, for papers by Tsukasa OkudaBreakdown of academic impact, for papers by Jeffrey L. Kutok